Company Overview of Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization is based in the United States.
177 North State Street
Chicago, IL 60601
Key Executives for Illinois Biotechnology Industry Organization
Chief Executive Officer and President
Vice Chairman of Human Health
Vice Chairman of Human Health and Director
Vice Chairman of Food & Agriculture and Director
Compensation as of Fiscal Year 2015.
Illinois Biotechnology Industry Organization Key Developments
The Illinois Biotechnology Industry Organization Announces Board Changes
Jul 27 15
The Illinois Biotechnology Industry Organization announced the election of new additions to its board of directors. Joining the company’s board are Walt Johnston and David Flowers. Walt Johnston is Vice President, US Marketing and Strategic New Product Planning for Astellas Pharma US Inc. Walt has over 20 years of experience in the pharmaceutical industry. David Flowers is a Director, Life Sciences Industry, for Deloitte Services LP.
Illinois Biotechnology Industry Organization and iBIO Institute Appoint Warren Ribley as President & CEO
Jan 6 15
The Illinois Biotechnology Industry Organization and its affiliate, the iBIO Institute announced that Warren Ribley has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February 2015. Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois’ Health Technology Innovation center (HTI). Ribley succeeds outgoing iBIO and iBIO Institute President & CEO, David Miller, who has led the iBIO organizations for over twelve years and last year announced his plans to retire in early 2015.
Illinois Biotechnology Industry Organization Announces Board Appointments
Dec 10 14
The Illinois Biotechnology Industry Organization (iBIO) announced the election of new additions to its board of directors. The new Board members, who include senior executives, policy, and investment experts from globally recognized corporations, add depth and prestige to an already-strong lineup of medical, agricultural, and industrial biotech representation. Joining iBIO’s board are Daniel Brennan of Lundbeck US, Jamie Oldani of Eli Lilly, Susanne Resatz of Vetter Development Services USA and Geeta Vemuri of Baxter Ventures. Daniel Brennan is vice president and general manager of Neurology and Business Development for Lundbeck US. Jamie Oldani serves as the Midwest Director of State Government Affairs for Eli Lilly and Company. Susanne Resatz, Ph.D., President of Vetter Development Services USA Inc., heads Vetter’s clinical manufacturing facility in suburban Chicago, Illinois. Geeta Vemuri joined Baxter in January 2012 as Vice President, Head of Baxter Ventures, the corporation's $200 million venture fund.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries